These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 20652657

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy.
    Leitch HA.
    Leuk Res; 2007 Dec; 31 Suppl 3():S7-9. PubMed ID: 18037416
    [Abstract] [Full Text] [Related]

  • 3. Iron chelation therapy in patients with myelodysplastic syndromes: consensus conference guidelines.
    Mittelman M, Lugassy G, Merkel D, Tamary H, Sarid N, Rachmilewitz E, Hershko C, MDS Israel Group, Israel Society of Hematology.
    Isr Med Assoc J; 2008 May; 10(5):374-6. PubMed ID: 18605364
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Approaches to transfusion therapy and iron overload in patients with sickle cell disease: results of an international survey.
    Vichinsky EP, Ohene-Frempong K, Transfusion Committee.
    Pediatr Hematol Oncol; 2011 Feb; 28(1):37-42. PubMed ID: 20673029
    [Abstract] [Full Text] [Related]

  • 6. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A, Fink D, Admoni O, Tennenbaum-Rakover Y, Levin C.
    Eur J Haematol; 2010 Jan 01; 84(1):72-8. PubMed ID: 19732137
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload.
    Gattermann N.
    Leuk Res; 2007 Dec 01; 31 Suppl 3():S10-5. PubMed ID: 18037413
    [Abstract] [Full Text] [Related]

  • 9. A new tool for the assessment of satisfaction with iron chelation therapy (ICT-Sat) for patients with β-thalassemia major.
    Elalfy MS, Massoud W, Elsherif NH, Labib JH, Elalfy OM, Elaasar S, von Mackensen S.
    Pediatr Blood Cancer; 2012 Jun 01; 58(6):910-5. PubMed ID: 22232075
    [Abstract] [Full Text] [Related]

  • 10. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
    Kim YR, Kim JS, Cheong JW, Song JW, Min YH.
    Acta Haematol; 2008 Jun 01; 120(3):182-9. PubMed ID: 19129689
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies.
    Taher A, Hershko C, Cappellini MD.
    Br J Haematol; 2009 Dec 01; 147(5):634-40. PubMed ID: 19681884
    [Abstract] [Full Text] [Related]

  • 14. Deferiprone, iron overload in a renal transplant patient.
    Bragadesh T, Bhandari S.
    QJM; 2014 Jun 01; 107(6):465-6. PubMed ID: 24352049
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Iron: The fifth horseman of the apocalypse?
    DeLoughery TG.
    Am J Hematol; 2009 May 01; 84(5):263-4. PubMed ID: 19358299
    [No Abstract] [Full Text] [Related]

  • 18. Iron loading and its clinical implications.
    Hershko C.
    Am J Hematol; 2007 Dec 01; 82(12 Suppl):1147-8. PubMed ID: 17963253
    [Abstract] [Full Text] [Related]

  • 19. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.
    Chacko J, Pennell DJ, Tanner MA, Hamblin TJ, Wonke B, Levy T, Thomas PW, Killick SB.
    Br J Haematol; 2007 Sep 01; 138(5):587-93. PubMed ID: 17610536
    [Abstract] [Full Text] [Related]

  • 20. Satisfaction and adherence in patients with iron overload receiving iron chelation therapy as assessed by a newly developed patient instrument.
    Rofail D, Abetz L, Viala M, Gait C, Baladi JF, Payne K.
    Value Health; 2009 Sep 01; 12(1):109-17. PubMed ID: 18637142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.